Markets rejoice over positive COVID-19 vaccine data- Monday Review, November 16

By: Miguel A. Rodriguez

10:56, 17 November 2020

Asian markets high over signing the world's largest regional free-trade partnership

The US

Moderna's positive data made the benchmarks close at record highs, even after the US reported more than 11 million cases. USA30 rose 1.60%, while USA500 went up 1.17%. TECH100 added 0.80%.

Gold climbed 0.3% to $1,891.60 per ounce.

Crude oil settled up at $41.34 per barrel, while Brent ended the day 2.4% higher at $43.82.


Asia and Australia

The markets surged after fifteen counties, including China, Japan, and Australia, signed the Regional Comprehensive Economic Partnership trade deal. The deal aims to liberalize trading between the countries.

Japan225 surged 2.05%, hitting a five-year high.

HongKong45 was up 0.63%.

Down under, Australia200gained 1.23%.

USD/JPY lost 0.07% to 104.55.



The stocks ended the day in the green, being moved by Moderna's data regarding its experimental COVID-19 vaccine. Germany30 and UK100 each closed 0.7% higher. France40 climbed 0.9%.

EUR/USD traded at 1.869 after it gained 0.3%.

Read here all about Moderna’s drug!


Share this article

This information prepared by is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.